DEVELOPMENT AND LICENSE AGREEMENTConfidential Treatment Requested • March 30th, 2015 • Pieris Pharmaceuticals, Inc. • Services-commercial physical & biological research • New York
THIS LICENSE AGREEMENT (the “Agreement”) is made and is effective as of this 7th day of October, 2013 (the “Effective Date”) by and between
CONFIDENTIAL TREATMENT REQUESTED Collaboration Research and Technology Licensing AgreementConfidential Treatment Requested • March 30th, 2015 • Pieris Pharmaceuticals, Inc. • Services-commercial physical & biological research
This Definitive Collaboration Research and Technology Licensing Agreement (this “Agreement”) is effective as of May 31, 2011 (the “Effective Date”), and is entered into by and between
JOINT DEVELOPMENT & LICENSE AGREEMENTJoint Development & License Agreement • March 30th, 2015 • Pieris Pharmaceuticals, Inc. • Services-commercial physical & biological research • England and Wales
This Joint Development and License Agreement (this “Agreement”) is made as of November 21st, 2013 (the “Effective Date”), by and between Pieris AG, a German stock corporation organized and existing under the laws of Germany, whose principal place of business is at Lise-Meitner-Straße 30, 85354 Freising, Germany (“Pieris”), and Stelis BioPharma Private Limited, formerly known as Agila Biotech Private Limited, a company incorporated under the Companies Act (India), 1956 and having its registered office at Strides House, Bilekahalli, Bannerghatta Road, Bangalore 560 076, India (“Stelis BioPharma”). Pieris and Stelis BioPharma may be referred to individually as a “Party” or together as the “Parties.”
CONFIDENTIAL TREATMENT REQUESTED RESEARCH AND LICENSING AGREEMENT betweenConfidential Treatment Requested • March 30th, 2015 • Pieris Pharmaceuticals, Inc. • Services-commercial physical & biological research
The Parties are jointly conducting research aimed at gaining fundamental insights in the realm of anticalins and lipocalins. To that effect the Parties signed a Research and Licensing Agreement on 26 June / 04 July 2003[***].
CONFIDENTIAL TREATMENT REQUESTED COLLABORATION AND LICENSE AGREEMENTConfidential Treatment Requested • March 30th, 2015 • Pieris Pharmaceuticals, Inc. • Services-commercial physical & biological research
This COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is entered into effective as of September 24th, 2010 (the “Effective Date”) by and between
